-
-
-
-
-
-
-
E413975-100mgInformationEganelisib (IPI-549) is a potent inhibitor ofPI3K-γwith >:100-fold selectivity over other lipid and protein kinases. The biochemicalIC50for PI3K-γ is 16 nM.TargetsPI3Kγ (Cell-free assay) 16 nMIn vitroIPI-549 is found to be a remarkably
-
E413975-25mgInformationEganelisib (IPI-549) is a potent inhibitor ofPI3K-γwith >:100-fold selectivity over other lipid and protein kinases. The biochemicalIC50for PI3K-γ is 16 nM.TargetsPI3Kγ (Cell-free assay) 16 nMIn vitroIPI-549 is found to be a remarkably
-
E413975-5mgInformationEganelisib (IPI-549) is a potent inhibitor ofPI3K-γwith >:100-fold selectivity over other lipid and protein kinases. The biochemicalIC50for PI3K-γ is 16 nM.TargetsPI3Kγ (Cell-free assay) 16 nMIn vitroIPI-549 is found to be a remarkably
-
E337818-100mgEGFR Inhibitor is a cell permeable compound that is a highly selective inhibitor of EGFR (epidermal growth factor receptor). Inhibition of EGFR has been shown to induce apoptosis. Mechanistic studies have shown that EGFR inhibition takes place via
-
E337818-1mgEGFR Inhibitor is a cell permeable compound that is a highly selective inhibitor of EGFR (epidermal growth factor receptor). Inhibition of EGFR has been shown to induce apoptosis. Mechanistic studies have shown that EGFR inhibition takes place via
-
E337818-25mgEGFR Inhibitor is a cell permeable compound that is a highly selective inhibitor of EGFR (epidermal growth factor receptor). Inhibition of EGFR has been shown to induce apoptosis. Mechanistic studies have shown that EGFR inhibition takes place via